Society guideline links: Bipolar disorder

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

International

●International College of Neuropsychopharmacology (CINP): Guidelines on the definition and evidence-based interventions for treatment-resistant bipolar disorder (2019)

●Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD): Guidelines for the management of patients with bipolar disorder (2018)

●CINP: Treatment guidelines for bipolar disorder (2017)

●The World Federation of Societies of Biological Psychiatry (WFSBP): Guidelines for the biological treatment of bipolar disorders – Acute and long-term treatment of mixed states in bipolar disorder (2017)

●ISBD: Task force report on antidepressant use in bipolar disorders (2013)

●WFSBP: Guidelines for the biological treatment of bipolar disorders – Update 2012 on the long-term treatment of bipolar disorder (published 2013)

●WFSBP: Guidelines for the biological treatment of bipolar disorders – Update on the treatment of acute bipolar depression (2010)

●ISBD: Consensus guidelines for the safety monitoring of bipolar disorder treatments (2009)

●WFSBP: Guidelines for the biological treatment of bipolar disorders – Update on the treatment of acute mania (2009)

Canada

●Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD): Guidelines for the management of patients with bipolar disorder (2018)

●CANMAT: Managing medical and psychiatric comorbidity in individuals with major depressive disorder and bipolar disorder (2012)

●CANMAT: Recommendations for the management of patients with mood disorders and comorbid anxiety disorders (2012)

●CANMAT: Recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder (2012)

●CANMAT: Recommendations for the management of patients with mood disorders and comorbid medical conditions – Diagnostic, assessment, and treatment principles (2012)

●CANMAT: Recommendations for the management of patients with mood disorders and comorbid metabolic disorders (2012)

●CANMAT: Recommendations for the management of patients with mood disorders and comorbid personality disorders (2012)

●CANMAT: Recommendations for the management of patients with mood disorders and comorbid substance use disorders (2012)

●CANMAT: Recommendations for the management of patients with mood disorders and select comorbid medical conditions (2012)

United States

●Florida Medicaid Drug Therapy Management Program for Behavioral Health (MDTMP): 2019-2020 Florida best practice psychotherapeutic medication guidelines for adults (2020)

●Choosing Wisely: Don't routinely prescribe an antipsychotic medication to treat behavioral and emotional symptoms of childhood mental disorders in the absence of approved or evidence supported indications (2013, revised 2014)

United Kingdom

●National Institute for Health and Care Excellence (NICE): Clinical guideline on bipolar disorder – Assessment and management (2014, updated 2020)

●British Association for Psychopharmacology (BAP): Evidence-based guidelines for treating bipolar disorder, revised 3rd edition recommendations (2016)

●NICE: Guideline on coexisting severe mental illness and substance misuse – Community health and social care services (2016)

●NICE: Quality standard on bipolar disorder in adults (2015)

●NICE: Quality standard on bipolar disorder, psychosis and schizophrenia in children and young people (2015)

●Scottish Intercollegiate Guidelines Network (SIGN): A national clinical guideline on the management of perinatal mood disorders (2012)

●NICE: Clinical guideline on coexisting severe mental illness (psychosis) and substance misuse – Assessment and management in healthcare settings (2011)

Australia-New Zealand

●Royal Australian & New Zealand College of Psychiatrists (RANZCP): Clinical practice guidelines for mood disorders (2020)

●RANZCP: Professional practice guideline 7 – Guidance for psychotropic medication use in children and adolescents (2015)

Japan

●[In Japanese] Japanese Society of Mood Disorders (JSMD): Treatment guidelines I – Bipolar disorder (2020)